“ The Carterra Vega platform is a technological leap forward—a true step change. Faster hit discovery with 48 parallel ...

VPS4B has emerged as a high-priority therapeutic target in oncology due to its overexpression in specific tumors and its synthetic-lethal relationship with its paralog, VPS4A, but despite its ...

Metrion Biosciences ("Metrion"), the specialist preclinical contract research organization (CRO) and a global leader in ion channel services, today announced the launch of its validated, ...

Eurofins CDMO Alphora is developing and launching AI-powered software for high-throughput salt and co-crystal screening.

The field of droplet microfluidics has emerged as a transformative approach for utilising microscale droplets as individual reaction compartments. This technology facilitates the precise manipulation ...

Combined market-leading speed and 27 channel capacity enable maximum flexibility and data generation New fluidics and clog detection systems further simplify operation and reduce instrument downtime ...

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...

OmniAb has introduced xPloration ®, a high-throughput single B-cell screening platform that integrates AI-assisted image analysis and machine learning for deep mining of immunized antibody repertoires ...

Anna-Maria earned her PhD in synthetic biology from Eindhoven University of Technology, where she honed her ability to transform complex science into real-world solutions. At Nanoworx, she oversees ...

Metrion Biosciences, today announced the launch of its validated, high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics. Validated drug discovery assay ...